Diagnostic and treatment of eye cancer

Eye cancer is a term used to define many types of tumors that can occurs in various parts of the eye. Eye cancer occurs when healthy cells in or around the eye change and grow uncontrollably, forming a mass called a tumor. High-throughput sequencing is helping to deeply understand the cancer genome, and the mechanisms that cause tumor progression and affect treatment response. The NGS (Next Generation Sequencing) technology is used for tumor profiling and assess signalling pathways within the tumor. The gene changes that make eye cancer cells, are different from normal cells and play an important role in treating eye melanomas, lymphomas, and other eye cancers in the future. There are different types of biological therapies to extravagance eye cancers.

The NITRO trial a type of biological therapy called ranibizumab for uveal melanoma. Ranibizumab is a monoclonal antibody. It works as targeting a protein on the cancer cell called vascular endothelial growth factor (VEGF).

    Related Conference of Diagnostic and treatment of eye cancer

    September 16-17, 2025

    20th International Conference on Ophthalmology and Vision Science

    Amsterdam, Netherlands
    September 22-23, 2025

    8th International Eye and Vision Congress

    Amsterdam, Netherlands
    October 20-21, 2025

    6th World Congress on Ophthalmology and Vision Science

    Barcelona, Spain
    November 03-04, 2025

    39th European Ophthalmology Congress

    Rome, Italy
    January 12-13, 2026

    26th Global Ophthalmologists Annual Meeting

    London, UK
    April 20-21, 2026

    3rd International Conference on Ophthalmology

    Barcelona, Spain

    Diagnostic and treatment of eye cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in